The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNippon Active . Regulatory News (NAVF)

Share Price Information for Nippon Active . (NAVF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 172.00
Bid: 171.00
Ask: 172.00
Change: 1.00 (0.58%)
Spread: 1.00 (0.585%)
Open: 170.00
High: 172.50
Low: 169.50
Prev. Close: 171.00
NAVF Live PriceLast checked at -
Nippon Active Value is an Investment Trust

To provide Shareholders with attractive capital growth through the active management of a focussed portfolio of quoted companies which have the majority of their operations in, or revenue derived from, Japan and that have been identified by the Investment Adviser as being undervalued.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rollover from abrdn Japan Investment Trust plc

18 May 2023 07:00

RNS Number : 7967Z
Nippon Active Value Fund PLC
18 May 2023
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL.

The information communicated in this announcement is deemed to constitute inside information as stipulated under the UK Version of Market Abuse Regulation (EU) No. 596/2014 (as incorporated into UK Law by virtue of the European Union (Withdrawal) Act 2018, and as subsequently amended ("MAR"). Upon the publication of this announcement, this information is considered to be in the public domain.

18 May 2023

Nippon Active Value Fund plc

LEI: 213800JOFEGZJYS21P75

Rollover from abrdn Japan Investment Trust plc

The Board of Nippon Active Value Fund plc (the "Company" or "NAVF") is pleased to announce that heads of terms have been agreed for a proposed rollover of the assets of abrdn Japan Investment Trust plc ("AJIT") into the Company.

The rollover, if approved by each company's shareholders, will be implemented through a scheme of reconstruction proposed by AJIT pursuant to section 110 of the Insolvency Act 1986. This would result in the voluntary liquidation of AJIT and the rollover of its assets into the Company in exchange for the issue of new NAVF shares to AJIT shareholders who elect to roll their investment into the enlarged fund. AJIT shareholders will be offered the option of a cash exit for up to 25 per cent. of AJIT's shares in issue, providing shareholders with the ability to realise part (or potentially all) of their investment at a 2 per cent. discount to formula asset value ("FAV") per share (the "Transaction").

New NAVF shares that are issued to AJIT shareholders will be issued on a FAV-to-FAV basis. FAVs will be calculated using the respective net asset values of each company, adjusted for costs payable by the relevant company in relation to the Transaction and any dividends and distributions declared by each party which have a record date prior to the effective date of the rollover of AJIT into NAVF.

Following completion of the Transaction, it is expected that one director from AJIT's board of directors, will join NAVF's Board, taking the number of directors on NAVF's Board to six.

Rising Sun Management Limited ("RSM") has agreed to pay for AJIT's costs to implement the Transaction up to a cap of £800,000.

Benefits of the Transaction

The Transaction would result in the Company becoming larger with a more diverse shareholder base and greater assets and is expected to improve liquidity in the Company's shares as well as spreading the fixed costs of the Company over a larger pool of assets.

Transfer of Listing Segment

Simultaneously to the issue of new shares in the Company to rolling AJIT shareholders, the Company has undertaken to move to a premium listing on the Main Market of the London Stock Exchange, which is expected to improve the access of retail investors to the enlarged Company and therefore its share rating and liquidity.

Investment Policy

Although the strategies of the Company and AJIT are similar with respect to their holdings of Japanese listed securities, in connection with the Company's proposed admission to the Official List of the Financial Conduct Authority ("FCA") and the acquisition of certain assets from AJIT, the Company's investment policy will need to be amended to, amongst other matters, increase the number of investments typically expected to be held in the portfolio and to provide greater flexibility in relation to the expected size (as a percentage of issued share capital of the portfolio company) of those investments. The amendments, if proposed, will be subject to the prior approval of shareholders.

Approvals

Implementation of the Transaction is subject, amongst other matters, to the final approval of the boards of directors of the Company and AJIT, the approval of the Company's shareholders, the approval of a prospectus in relation to the Company's shares and its move to the Official List by the FCA, a clearance from HMRC in respect of the Transaction and the approval by the shareholders of AJIT. A circular providing further details of the Transaction and convening a general meeting to seek the necessary shareholder approvals will be published by the Company alongside the prospectus as soon as practicable. It is anticipated that the Transaction will be implemented in the third quarter of this year.

Joh. Berenberg, Gossler & Co KG, London Branch has been appointed as Sponsor and Financial Adviser to the Company in relation to the Transaction.

City Code

In accordance with customary practice for section 110 schemes, the City Code on Takeovers and Mergers is not expected to apply to the Transaction.

Rosemary Morgan, Chairman of the Company commented:

"I am delighted that we have reached a preliminary agreement in relation to this combination. The increased assets which the Transaction would deliver will continue the growth and success of the Company, benefitting both our existing shareholders, but also the AJIT shareholders who become part of a larger entity with an excellent track record and greater economies of scale. The Board is grateful to RSM for the support it continues to show the Company, in this case by generously paying a substantial proportion of the Transaction costs. We look forward to a swift conclusion of the Transaction and to welcoming AJIT shareholders to our enlarged Company."

 

Enquiries

Berenberg Gillian Martin / Dan Gee-Summons/ Arnav Kapoor

Tel: +44 (0)20 3207 7800

Company Secretary Brian Smith/Maria Matheou

Tel: +44 (0) 20 3327 9720

 

Important information relating to Sponsor and Financial Adviser

Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg") which is authorised and regulated by the German Federal Financial Supervisory Authority and deemed authorised and subject to limited regulation in the United Kingdom by the FCA, is acting solely as sponsor and financial adviser to the Company and for no one else in relation to the proposed transaction, and will not be responsible to anyone other than the Company for providing the protections afforded to the clients of Berenberg or for providing advice in relation to the proposed transaction, the contents of this document or any other matters described in this announcement.

Apart from the responsibilities and liabilities, if any, which may be imposed upon Berenberg by FSMA or the regulatory regime established thereunder, Berenberg does not accept any responsibility whatsoever or make any representation or warranty, express or implied, concerning the contents of this announcement, including as to its accuracy, completeness or verification, or for any other statement made or purported to be made by it, or on its behalf, in connection with the Company or the proposed transaction, whether as to the past or future.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCVDLFFXELBBBK
Date   Source Headline
3rd May 202412:00 pmRNSNet Asset Value(s)
2nd May 202412:00 pmRNSNet Asset Value(s)
1st May 202412:00 pmRNSNet Asset Value(s)
30th Apr 202412:00 pmRNSNet Asset Value(s)
29th Apr 202412:00 pmRNSNet Asset Value(s)
26th Apr 202412:00 pmRNSNet Asset Value(s)
25th Apr 202412:00 pmRNSNet Asset Value(s)
24th Apr 202412:00 pmRNSNet Asset Value(s)
23rd Apr 202412:00 pmRNSNet Asset Value(s)
22nd Apr 202412:00 pmRNSNet Asset Value(s)
19th Apr 202412:18 pmRNSNet Asset Value(s)
18th Apr 202411:49 amRNSNet Asset Value(s)
17th Apr 202412:00 pmRNSNet Asset Value(s)
16th Apr 202412:00 pmRNSNet Asset Value(s)
15th Apr 202412:00 pmRNSNet Asset Value(s)
12th Apr 202412:30 pmRNSNet Asset Value(s)
11th Apr 202412:00 pmRNSNet Asset Value(s)
10th Apr 202411:00 amRNSNet Asset Value(s)
9th Apr 202412:00 pmRNSNet Asset Value(s)
9th Apr 202411:20 amRNSMonthly Factsheet
9th Apr 20247:00 amRNSDirector/PDMR Shareholding
8th Apr 202412:00 pmRNSNet Asset Value(s)
5th Apr 202412:00 pmRNSNet Asset Value(s)
4th Apr 202412:00 pmRNSNet Asset Value(s)
3rd Apr 202412:00 pmRNSNet Asset Value(s)
3rd Apr 20247:01 amRNSDividend Declaration
3rd Apr 20247:00 amRNSFinal Results
2nd Apr 202412:20 pmRNSNet Asset Value(s)
28th Mar 202410:42 amRNSNet Asset Value(s)
27th Mar 202412:00 pmRNSNet Asset Value(s)
26th Mar 202412:00 pmRNSNet Asset Value(s)
25th Mar 202410:41 amRNSNet Asset Value(s)
22nd Mar 202412:00 pmRNSNet Asset Value(s)
21st Mar 202412:00 pmRNSNet Asset Value(s)
20th Mar 202412:00 pmRNSNet Asset Value(s)
19th Mar 202412:00 pmRNSNet Asset Value(s)
18th Mar 202412:00 pmRNSNet Asset Value(s)
15th Mar 202412:00 pmRNSNet Asset Value(s)
14th Mar 202412:00 pmRNSNet Asset Value(s)
13th Mar 202412:00 pmRNSNet Asset Value(s)
12th Mar 20244:38 pmRNSMonthly Factsheet
12th Mar 202412:00 pmRNSNet Asset Value(s)
11th Mar 202412:00 pmRNSNet Asset Value(s)
8th Mar 202412:00 pmRNSNet Asset Value(s)
7th Mar 202412:00 pmRNSNet Asset Value(s)
6th Mar 20242:00 pmRNSNet Asset Value(s)
5th Mar 202412:00 pmRNSNet Asset Value(s)
4th Mar 202412:00 pmRNSNet Asset Value(s)
1st Mar 202412:00 pmRNSNet Asset Value(s)
29th Feb 202411:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.